gabexate has been researched along with bromhexine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Ikarashi, K; Kato, M; Sasahara, K; Tanno, K | 1 |
Drakoulis, N; Ion, GND; Moschos, SA; Nikolouzakis, TK; Nitulescu, G; Nitulescu, GM; Paunescu, H; Petrakis, D; Spandidos, DA; Tsatsakis, A | 1 |
1 review(s) available for gabexate and bromhexine
Article | Year |
---|---|
Comprehensive analysis of drugs to treat SARS‑CoV‑2 infection: Mechanistic insights into current COVID‑19 therapies (Review).
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Betacoronavirus; Bromhexine; Chlorpromazine; Clinical Trials as Topic; Coronavirus Infections; COVID-19; Diminazene; Drug Repositioning; Esters; Gabexate; Guanidines; Humans; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Receptor, Angiotensin, Type 1; Recombinant Proteins; SARS-CoV-2; Signal Transduction; Virus Internalization | 2020 |
1 other study(ies) available for gabexate and bromhexine
Article | Year |
---|---|
[Incompatibility of cefotiam dihydrochloride in parenteral preparation by high-performance liquid chromatography].
Topics: Bromhexine; Cefotaxime; Cefotiam; Chromatography, High Pressure Liquid; Dipyridamole; Drug Combinations; Drug Incompatibility; Drug Interactions; Drug Stability; Gabexate; Guanidines; Hydrogen-Ion Concentration; Solutions | 1982 |